KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomarin Pharmaceutical (BMRN) Tax Rate (2017 - 2025)

Biomarin Pharmaceutical's Tax Rate history spans 16 years, with the latest figure at 71.52% for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate fell 9787.0% year-over-year to 71.52%, compared with a TTM value of 27.69% through Dec 2025, up 648.0%, and an annual FY2025 reading of 27.69%, up 648.0% over the prior year.
  • Tax Rate for Q4 2025 was 71.52% at Biomarin Pharmaceutical, down from 16.79% in the prior quarter.
  • The five-year high for Tax Rate was 98.58% in Q4 2022, with the low at 249.37% in Q3 2022.
  • Average Tax Rate over 5 years is 0.59%, with a median of 17.44% recorded in 2024.
  • Year-over-year, Tax Rate crashed -136108bps in 2021 and then skyrocketed 25247bps in 2023.
  • Tracing BMRN's Tax Rate over 5 years: stood at 13.03% in 2021, then soared by 656bps to 98.58% in 2022, then tumbled by -106bps to 5.42% in 2023, then skyrocketed by 586bps to 26.35% in 2024, then crashed by -371bps to 71.52% in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Tax Rate are 71.52% (Q4 2025), 16.79% (Q3 2025), and 19.25% (Q2 2025).